A Standardized Extract of Roscoe Regulates Clinical and Biological Outcomes in Two Different EAE Mouse Models

Overview

Journal Biomedicines

Specialty Biomedical Engineering

Date 2025 Feb 26

PMID 40002693

Authors

Vittoria Borgonetti

Paolo Governa

Martina Morozzi

Chiara Sasia

Giacomina Videtta

Marco Biagi

Nicoletta Galeotti

Affiliations

Soon will be listed here.

Abstract

: Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system characterized by demyelination and neuronal damage. Current MS therapies are unsatisfactory, and new therapies are encouraged. A correlation between nutritional intake and MS has been speculated. Supplementation of approved immunomodulatory therapy with herbal medicines possessing antioxidant and anti-inflammatory activities could provide benefits to MS patients. Ginger is one of the most widely consumed dietary supplements in the world, commonly used in traditional medicine. Studies demonstrated that ginger may also be beneficial in the management of neurodegenerative diseases. The aim of this study is to investigate the MS therapeutic potential of ginger. : A standardized Roscoe extract (ZOE) was orally administered for 14 days. Two experimental autoimmune encephalomyelitis (EAE) models in mice were used. The PLP-EAE relapsing-remitting model and MOG-EAE chronic model. Clinical score, von Frey, hot plate, and rotarod tests were used for behavioral tests. ELISA and Western blotting were used to measure cytokines levels. Evans Blue content was determined spectrophotometrically. : ZOE attenuated motor disability and pain hypersensitivity in both models had no effect on body weight loss. ZOE reduced the blood-brain barrier (BBB) permeability in the PLP-EAE models and reduced levels of circulating cytokines (Il-6, IL-17) in the MOG-EAE model. ZOE attenuated spinal cytokines overexpression in both models. : ZOE improves EAE symptoms and attenuates the proinflammatory response in both models, representing a promising nutraceutical support to the conventional therapeutic approach to MS.

References

Namiecinska M, Piatek P, Lewkowicz P . Nervonic Acid Synthesis Substrates as Essential Components in Profiled Lipid Supplementation for More Effective Central Nervous System Regeneration. Int J Mol Sci. 2024; 25(7). PMC: 11011827. DOI: 10.3390/ijms25073792. View

Balasa R, Barcutean L, Mosora O, Manu D . Reviewing the Significance of Blood-Brain Barrier Disruption in Multiple Sclerosis Pathology and Treatment. Int J Mol Sci. 2021; 22(16). PMC: 8395058. DOI: 10.3390/ijms22168370. View

Dolati S, Babaloo Z, Ayromlou H, Ahmadi M, Rikhtegar R, Rostamzadeh D . Nanocurcumin improves regulatory T-cell frequency and function in patients with multiple sclerosis. J Neuroimmunol. 2019; 327:15-21. DOI: 10.1016/j.jneuroim.2019.01.007. View

Sanna M, Ghelardini C, Galeotti N . Activation of JNK pathway in spinal astrocytes contributes to acute ultra-low-dose morphine thermal hyperalgesia. Pain. 2015; 156(7):1265-1275. DOI: 10.1097/j.pain.0000000000000164. View

Aharoni R, Vainshtein A, Stock A, Eilam R, From R, Shinder V . Distinct pathological patterns in relapsing-remitting and chronic models of experimental autoimmune enchephalomyelitis and the neuroprotective effect of glatiramer acetate. J Autoimmun. 2011; 37(3):228-41. DOI: 10.1016/j.jaut.2011.06.003. View

Motulsky H, Brown R . Detecting outliers when fitting data with nonlinear regression - a new method based on robust nonlinear regression and the false discovery rate. BMC Bioinformatics. 2006; 7:123. PMC: 1472692. DOI: 10.1186/1471-2105-7-123. View

Zajicek J, Sanders H, Wright D, Vickery P, Ingram W, Reilly S . Cannabinoids in multiple sclerosis (CAMS) study: safety and efficacy data for 12 months follow up. J Neurol Neurosurg Psychiatry. 2005; 76(12):1664-9. PMC: 1739436. DOI: 10.1136/jnnp.2005.070136. View

Filippi M, Bar-Or A, Piehl F, Preziosa P, Solari A, Vukusic S . Multiple sclerosis. Nat Rev Dis Primers. 2018; 4(1):43. DOI: 10.1038/s41572-018-0041-4. View

Fajrin F, Purwandhono A, Christianty F, Sulistyaningrum G, Afifah -, Imandasari N . Antihyperalgesia potency of Zingiber officinale var. Rubrum in inflammatory and neuropathy-induced chronic pain condition in mice. Pak J Pharm Sci. 2019; 32(4):1663-1669. View

10.

Borgonetti V, Roberts A, Bajo M, Galeotti N, Roberto M . Chronic alcohol induced mechanical allodynia by promoting neuroinflammation: A mouse model of alcohol-evoked neuropathic pain. Br J Pharmacol. 2023; 180(18):2377-2392. PMC: 10898491. DOI: 10.1111/bph.16091. View

11.

Petracca M, Quarantelli M, Moccia M, Vacca G, Satelliti B, DAmbrosio G . ProspeCtive study to evaluate efficacy, safety and tOlerability of dietary supplemeNT of Curcumin (BCM95) in subjects with Active relapsing MultIple Sclerosis treated with subcutaNeous Interferon beta 1a 44 mcg TIW (CONTAIN): A randomized,.... Mult Scler Relat Disord. 2021; 56:103274. DOI: 10.1016/j.msard.2021.103274. View

12.

Hauser S, Cree B . Treatment of Multiple Sclerosis: A Review. Am J Med. 2020; 133(12):1380-1390.e2. PMC: 7704606. DOI: 10.1016/j.amjmed.2020.05.049. View

13.

Yallapu M, Nagesh P, Jaggi M, Chauhan S . Therapeutic Applications of Curcumin Nanoformulations. AAPS J. 2015; 17(6):1341-56. PMC: 4627456. DOI: 10.1208/s12248-015-9811-z. View

14.

Borgonetti V, Governa P, Biagi M, Pellati F, Galeotti N . Zingiber officinale Roscoe rhizome extract alleviates neuropathic pain by inhibiting neuroinflammation in mice. Phytomedicine. 2020; 78:153307. DOI: 10.1016/j.phymed.2020.153307. View

15.

Dendrou C, Fugger L, Friese M . Immunopathology of multiple sclerosis. Nat Rev Immunol. 2015; 15(9):545-58. DOI: 10.1038/nri3871. View

16.

Curtis M, Alexander S, Cirino G, Docherty J, George C, Giembycz M . Experimental design and analysis and their reporting II: updated and simplified guidance for authors and peer reviewers. Br J Pharmacol. 2018; 175(7):987-993. PMC: 5843711. DOI: 10.1111/bph.14153. View

17.

Song L, Zhou Q, Wang H, Liao F, Hua L, Zhang H . Chinese herbal medicine adjunct therapy in patients with acute relapse of multiple sclerosis: A systematic review and meta-analysis. Complement Ther Med. 2017; 31:71-81. DOI: 10.1016/j.ctim.2017.02.004. View

18.

Petersen M, Bergien S, Staerk D . A systematic review of possible interactions for herbal medicines and dietary supplements used concomitantly with disease-modifying or symptom-alleviating multiple sclerosis drugs. Phytother Res. 2021; 35(7):3610-3631. DOI: 10.1002/ptr.7050. View

19.

Han J, Li X, Ye Z, Lu X, Yang T, Tian J . Treatment with 6-Gingerol Regulates Dendritic Cell Activity and Ameliorates the Severity of Experimental Autoimmune Encephalomyelitis. Mol Nutr Food Res. 2019; 63(18):e1801356. DOI: 10.1002/mnfr.201801356. View

20.

Sweeney M, Sagare A, Zlokovic B . Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders. Nat Rev Neurol. 2018; 14(3):133-150. PMC: 5829048. DOI: 10.1038/nrneurol.2017.188. View